MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q2 2024

SEC EDGAR SourceSEC Filings

Top Holdings96 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.9M$1.3B8.8%$224.63+96.76%
22 qtrssince 2019-Q1
Increased
63

APPLE INC

4.7M$984.2M6.7%$141.07+47.89%
22 qtrssince 2019-Q1
Increased
75

ALPHABET INC-CL A

5M$917.7M6.2%$100.48+80.13%
22 qtrssince 2019-Q1
Increased
62

APPLIED MATERIALS INC

3.1M$727.9M4.9%$122.44+89.55%
14 qtrssince 2021-Q1
Increased
59

META PLATFORMS INC-CLASS A

1.2M$623.8M4.2%$273.15+83.69%
17 qtrssince 2020-Q2
Increased
59

AMAZON.COM INC

3M$579.3M3.9%$122.92+57.21%
22 qtrssince 2019-Q1
Increased
64

NVIDIA CORP

4.4M$545.4M3.7%$114.38+7.96%
22 qtrssince 2019-Q1
Increased
93
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

28.8M$468.6M3.2%$9.50+71.03%
19 qtrssince 2019-Q4
Increased
59

MASTERCARD INC - A

1M$454.1M3.1%$341.13+28.03%
14 qtrssince 2021-Q1
Increased
58

WALMART INC

5.5M$375M2.5%$53.71+24.24%
22 qtrssince 2019-Q1
Increased
53
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

9M$357.3M2.4%$31.79+23.92%
5 qtrssince 2023-Q2
Increased
55

UNITEDHEALTH GROUP INC

677,428$345M2.3%$472.73+4.37%
7 qtrssince 2022-Q4
Increased
53

JPMORGAN CHASE & CO

1.7M$343.8M2.3%$146.85+32.72%
4 qtrssince 2023-Q3
Increased
54

ABBOTT LABORATORIES

3.1M$323.4M2.2%$98.75+0.37%
16 qtrssince 2020-Q3
Increased
59

NOVA LTD

1.3M$302.8M2.1%$49.23+376.41%
22 qtrssince 2019-Q1
Increased
53
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

1.5M$266.9M1.8%$89.02+91.34%
7 qtrssince 2022-Q4
Increased
49

ABBVIE INC

1.5M$264.1M1.8%$116.69+36.39%
17 qtrssince 2020-Q2
Unchanged
0

THERMO FISHER SCIENTIFIC INC

472,106$261.1M1.8%$410.11+34.18%
22 qtrssince 2019-Q1
Increased
49

MICRON TECHNOLOGY INC

2M$260.3M1.8%$71.40+83.02%
18 qtrssince 2020-Q1
Decreased
0

ADOBE INC

460,392$255.8M1.7%$444.00+25.12%
10 qtrssince 2022-Q1
Increased
61
$14.7B
AUM
96
Positions
Q2 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
+63%Q1'23$9.7B+12%Q2'23$10.8B+2%Q3'23$11B+8%Q4'23$11.9B+12%Q1'24$13.3B+10%Q2'24$14.7B
Activity profile
$ moved · Q2'24
New16%Increased57%Decreased14%Exited13%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.3 years
<1Q11%1-4Q14%1-2Y31%2Y+44%

MENORA MIVTACHIM HOLDINGS LTD. manages $14.7B across 96 positions as of Q2 2024. Top holdings: MSFT (8.8%), AAPL (6.7%), GOOGL (6.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q2 2024 Summary

Active quarter - 14 new positions, 6 exits, 46 increased. Top move: NVDA (INCREASED, conviction 93). Portfolio: $14.7B across 96 positions.

Top holdings by portfolio weight

Total AUM$15B
MSFT8.75%
AAPL6.69%
GOOGL6.24%
AMAT4.95%
META4.24%
AMZN3.94%
NVDA3.71%
TEVA3.18%
MA3.09%
WMT2.55%
Other2.43%

Portfolio allocation by GICS sector

Sectors11
Technology35.59%
Healthcare11.70%
Unknown11.31%
Communication Services10.65%
Financial Services10.16%
Consumer Cyclical7.72%
Consumer Defensive4.04%
Basic Materials2.88%
Industrials2.61%
Real Estate1.81%
Other1.51%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used